Sarah Zierold

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life" [Eur J Cancer 176 (2022) 88-99].

Corrigendum to "Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life" [Eur J Cancer 176 (2022) 88-99].

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 21, 2025

Bullet ant-more than just a painful sting

Bullet ant-more than just a painful sting

Journal: Dermatologie (Heidelberg, Germany)

Published: March 28, 2024

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors.

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 10, 2024

Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level.

Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level.

Journal: JAAD international

Published: November 22, 2023

Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid.

Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 08, 2023

Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study.

Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: July 17, 2023

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors.

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors.

Journal: Cancers

Published: March 15, 2023

Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases.

Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases.

Journal: Data in brief

Published: September 06, 2022

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.

Journal: Data in brief

Published: August 18, 2022

Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.

Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 05, 2022

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma.

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma.

Journal: Cancers

Published: May 27, 2022

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 20, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026